x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001049
| Product Information | |
|---|---|
| Product Name | AKT2 ELISA Kit |
| Species | Human; Mouse; Rat |
| Description | AKT2 ELISA Kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of AKT2 protein in cell culture extracts, cell culture supernatant, and tissue extracts. It uses our proprietary ELISA technology. Quantitate AKT2 with 5 pg/mL sensitivity ELISA technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our ELISA plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. |
| Sample Types | Cell Culture Supernatant, Cell Culture Extracts, Tissue Extracts |
| Detection Range | 78.13 pg/mL - 5000 pg/mL |
| Sensitivity | 5 pg/mL |
| Precision | CV: < 10% |
| Target Information | |
|---|---|
| Target Name | AKT2 |
| UniProt No. | P31751 |
| Gene ID | 208 |
| Target Description | General protein kinase capable of phosphorylating several known proteins. |
| Alternative Names | Akt2; AKT2_HUMAN; HIHGHH; Murine thymoma viral (v-akt) homolog 2; murine thymoma viral (v-akt) homolog-2; Oncogene AKT2 protein kinase B beta; PKB; PKB beta; PKBB; PKBBETA; PRKBB; Protein kinase Akt 2; Protein kinase Akt-2; Protein kinase B beta; RAC beta; rac protein kinase beta; RAC-BETA; RAC-beta serine/threonine-protein kinase; RAC-PK-beta; RACbeta; v akt murine thymoma viral oncogene homolog 2; V-AKT murine thymoma viral oncogene homolog 2 |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
